PPIDT00379
Drug Information
| Name | Nonacog beta pegol |
|---|---|
| Sequence | YNSGKLXXFVQGNLXRXCMXXKCSFXXARXVFXNTXRTTXFWKQYVDGDQCESNPCLNGGSCKDDINSYECWCPFGFEGKNCELDVTCNIKNGRCEQFCKNSADNKVVCSCTEGYRLAENQKSCEPAVPFPCGRVSVSQTSKLTRAEAVFPDVDYVNSTEAETILDNITQSTQSFNDFTRVVGGEDAKPGQFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCVETGVKITVVAGEHNIEETEHTEQKRNVIRIIPHHNYNAAINKYNHDIALLELDEPLVLNSYVTPICIADKEYTNIFLKFGSGYVSGWGRVFHKGRSALVLQYLRVPLVDRATCLRSTKFTIYNNMFCAGFHEGGRDSCQGDSGGPHVTEVEGTSFLTGIISWGEECAMKGKYGIYTKVSRYVNWIKEKTKLT |
| DrugBank_ID | DB13933 |
| Type | biotech |
| Indication | Nonacog beta pegol is indicated in adults and children with hemophilia B (congenital factor IX deficiency or Christmas disease) for control and prevention of bleeding episodes as well as control and prevention of bleeding in the perioperative setting.[L41175, L41180, L41185, L43682] It is also used for routine prophylaxis to prevent or reduce the frequency of bleeding episodes.[L41180, L43682] |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| Powder, for solution | Intravenous |
1000 unit / vial
|
| Powder, for solution | Intravenous |
2000 unit / vial
|
| Powder, for solution | Intravenous |
3000 unit / vial
|
| Powder, for solution | Intravenous |
500 unit / vial
|
| Injection, powder, for solution | Intravenous |
1000 IU
|
| Injection, powder, for solution | Intravenous |
2000 IU
|
| Injection, powder, for solution | Intravenous |
3000 IU
|
| Injection, powder, for solution | Intravenous |
500 IU
|
| Solution | Intravenous |
1000 UI
|
| Injection, solution | — |
1000 iu
|
| Injection, powder, lyophilized, for solution | Intravenous |
1000 IU
|
| Injection, powder, lyophilized, for solution | Intravenous |
100000000 IU
|
| Injection, solution | — |
2000 iu
|
| Injection, solution | — |
500 iu
|